Design Therapeutics Eulerpool Ziņas

Design Therapeutics Akciju Ziņas

Design Therapeutics tiek uzmanīgi vēroti no žurnālistu un investoru puses visā pasaulē. Jaunākās Design Therapeutics ziņas mēs apkopojam šeit.

• 4. jūnijs ·

  Yahoo
  Design Therapeutics Announces Start of Friedreich Ataxia Patient Dosing Ex-U.S. in its RESTORE-FA Phase 1/2 Multiple-Ascending Dose Trial of DT-216P2
• 28. maijs ·

  Yahoo
  Design Therapeutics to Participate in 2025 Jefferies Global Healthcare Conference
• 13. maijs ·

  Yahoo
  Design Therapeutics to Participate in 2025 RBC Capital Markets Healthcare Conference
• 2. maijs ·

  Yahoo
  Design Therapeutics reports positive outcomes from trial of DT-168 eye drops
• 1. maijs ·

  Yahoo
  Design Therapeutics Announces Favorable Phase 1 Data for DT-168 Supporting Advancement into Phase 2 Biomarker Trial for Patients with Fuchs Endothelial Corneal Dystrophy
• 18. aprīlis ·

  Yahoo
  April 2025's Promising Penny Stocks
• 17. aprīlis ·

  Yahoo
  Design Therapeutics Appoints Veteran Industry Executive Chris Storgard, M.D., as Chief Medical Officer
• 17. aprīlis ·

  Yahoo
  Bright Peak Therapeutics Appoints John Schmid to its Board of Directors
• 22. janvāris ·

  Yahoo
  3 Promising US Penny Stocks With Market Caps Under $900M
• 21. janvāris ·

  SeekingAlpha
  Solid Biosciences: Differentiating Factors Of SGT-212 To Set Itself Apart